Barlow David S

USNatural personDirector

FrançaisSign in Try free 14d

Insider

Barlow David S

USNatural personDirector

Transactions

122

Issuers

Buys / Sells

17/75

Last tx

28 Jan 2011

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
Molecular Insight Pharmaceuticals, Inc.	2,382,377	reported	28 Jan 2011	tx 144+2,088,697−553,241
NEW RIVER PHARMACEUTICALS INC	20,000	reported	25 Jan 2007	tx 16+105,000−80,000
Viskase Holdings, Inc.	209	reported	31 Dec 2003	tx 2+553

Recent transactions

Date	Type	Issuer	Qty	Price	Signals
28 Jan 2011	SALE	Molecular Insight Pharmaceuticals, Inc.	17,000	0.15 USD
28 Jan 2011	SALE	Molecular Insight Pharmaceuticals, Inc.	6,000	0.14 USD
28 Jan 2011	SALE	Molecular Insight Pharmaceuticals, Inc.	9,000	0.17 USD
28 Jan 2011	SALE	Molecular Insight Pharmaceuticals, Inc.	21,000	0.18 USD	anomaly
27 Jan 2011	SALE	Molecular Insight Pharmaceuticals, Inc.	5,000	0.18 USD
27 Jan 2011	SALE	Molecular Insight Pharmaceuticals, Inc.	33,000	0.17 USD	anomaly
28 Jan 2011	SALE	Molecular Insight Pharmaceuticals, Inc.	6,000	0.16 USD
16 Dec 2010	SALE	Molecular Insight Pharmaceuticals, Inc.	24,000	0.21 USD	anomaly
16 Dec 2010	SALE	Molecular Insight Pharmaceuticals, Inc.	19,000	0.22 USD	anomaly
16 Dec 2010	SALE	Molecular Insight Pharmaceuticals, Inc.	2,000	0.23 USD	anomaly
17 Dec 2010	SALE	Molecular Insight Pharmaceuticals, Inc.	31,000	0.19 USD	anomaly
17 Dec 2010	SALE	Molecular Insight Pharmaceuticals, Inc.	2,000	0.21 USD	anomaly
17 Dec 2010	SALE	Molecular Insight Pharmaceuticals, Inc.	122,000	0.20 USD	anomaly
14 Jan 2010	SALE	Molecular Insight Pharmaceuticals, Inc.	500	1.95 USD
14 Jan 2010	SALE	Molecular Insight Pharmaceuticals, Inc.	500	1.99 USD
14 Jan 2010	SALE	Molecular Insight Pharmaceuticals, Inc.	500	1.96 USD
14 Jan 2010	SALE	Molecular Insight Pharmaceuticals, Inc.	300	2.05 USD
14 Jan 2010	SALE	Molecular Insight Pharmaceuticals, Inc.	1,000	2.04 USD
14 Jan 2010	SALE	Molecular Insight Pharmaceuticals, Inc.	500	1.95 USD
14 Jan 2010	SALE	Molecular Insight Pharmaceuticals, Inc.	314	1.97 USD
14 Jan 2010	SALE	Molecular Insight Pharmaceuticals, Inc.	500	1.97 USD
14 Jan 2010	SALE	Molecular Insight Pharmaceuticals, Inc.	186	1.95 USD	anomaly
12 Jan 2010	SALE	Molecular Insight Pharmaceuticals, Inc.	200	2.06 USD	anomaly
14 Jan 2010	SALE	Molecular Insight Pharmaceuticals, Inc.	500	1.95 USD
14 Jan 2010	SALE	Molecular Insight Pharmaceuticals, Inc.	500	2.05 USD

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
Molecular Insight Pharmaceuticals, Inc.	2,382,377	reported	28 Jan 2011	tx 144+2,088,697−553,241
NEW RIVER PHARMACEUTICALS INC	20,000	reported	25 Jan 2007	tx 16+105,000−80,000
Viskase Holdings, Inc.	209	reported	31 Dec 2003	tx 2+553